Magnetic hydrogels for levodopa release and cell stimulation triggered by external magnetic field

Colloids and Surfaces B: Biointerfaces

Volumn 167, Issue , 2018, Pages 415-424

  Kondaveeti, Stalin ^a   Semeano, Ana Teresa Silva ^a   Cornejo, Daniel R ^a   Ulrich, Henning ^a   Petri, Denise Freitas Siqueira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Drug release; Levodopa; Magnetic hydrogel; Neural cell; Sodium alginate; Static magnetic field; Xanthan gum

Indexed keywords

CELL PROLIFERATION; CELLS; CONTROLLED DRUG DELIVERY; CYTOLOGY; DRUG PRODUCTS; ELECTROMAGNETIC FIELD EFFECTS; NANOMAGNETICS; NANOPARTICLES; SODIUM ALGINATE; TARGETED DRUG DELIVERY; XANTHAN GUM;

DRUG RELEASE; LEVODOPA; MAGNETIC HYDROGELS; NEURAL CELLS; STATIC MAGNETIC FIELDS;

HYDROGELS;

ALGINIC ACID; CALCIUM ION; DOPAMINE RECEPTOR; LEVODOPA; MAGNETIC NANOPARTICLE; XANTHAN; BACTERIAL POLYSACCHARIDE; DOPAMINE RECEPTOR STIMULATING AGENT; GLUCURONIC ACID; HEXURONIC ACID;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CHARGE DENSITY; CHEMICAL PHENOMENA; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG RELEASE; EXTERNAL MAGNETIC FIELD; HUMAN; HUMAN CELL; IN VITRO STUDY; LOADING EFFICIENCY; MAGNETIC FIELD; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SH-SY5Y CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; HYDROGEL; MAGNETISM; PH; PROCEDURES; SCANNING ELECTRON MICROSCOPY; TUMOR CELL LINE;

ALGINATES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOPAMINE AGENTS; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; HYDROGELS; HYDROGEN-ION CONCENTRATION; LEVODOPA; MAGNETIC FIELDS; MAGNETICS; MICROSCOPY, ELECTRON, SCANNING; POLYSACCHARIDES, BACTERIAL;

EID: 85046148742     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2018.04.040     Document Type: Article

References (47)

1. Bueno, V.B., Silva, A.M., Barbosa, L.R.S., Catalani, L.H., Teixeira-Neto, É., Cornejo, D.R., et al. Hybrid composites of xanthan and magnetic nanoparticles for cellular uptake. Chem. Commun. 49 (2013), 9911–9913.
2. Kondaveeti, S., Cornejo, D.R., Petri, D.F.S., Alginate/magnetite hybrid beads for magnetically stimulated release of dopamine. Colloids Surf. B 138 (2016), 94–101.
3. Castro, P.S., Bertotti, M., Naves, A.F., Catalani, L.H., Cornejo, D.R., Bloisi, G.D., et al. Hybrid magnetic scaffolds: the role of scaffolds charge on the cell proliferation and Ca 2+ ions permeation. Colloids Surf. B 156 (2017), 388–396.
4. Glaser, T., Bueno, V.B., Cornejo, D.R., Petri, D.F., Ulrich, H., Neuronal adhesion, proliferation and differentiation of embryonic stem cells on hybrid scaffolds made of xanthan and magnetite nanoparticles. Biomed. Mater., 10, 2015, 045002.
5. Finotelli, P.V., Da Silva, D., Sola-Penna, M., Rossi, A.M., Farina, M., Andrade, L.R., et al. Microcapsules of alginate/chitosan containing magnetic nanoparticles for controlled release of insulin. Colloids Surf. B 81 (2010), 206–211.
6. Mahdavinia, G.R., Etemadi, H., Soleymani, F., Magnetic/pH-responsive beads based on caboxymethyl chitosan and κ-carrageenan and controlled drug release. Carbohydr. Polym. 128 (2015), 112–121.
7. Hoare, T., Timko, B.P., Santamaria, J., Goya, G.F., Irusta, S., Lau, S., et al. Magnetically triggered nanocomposite membranes: a versatile platform for triggered drug release. Nano Lett. 11 (2011), 1395–1400.
8. Likhitkar, S., Bajpai, A., Magnetically controlled release of cisplatin from superparamagnetic starch nanoparticles. Carbohydr. Polym. 87 (2012), 300–308.
9. Davila, A., Fleissner, G., Winklhofer, M., Petersen, N., A new model for a magnetoreceptor in homing pigeons based on interacting clusters of superparamagnetic magnetite. Phys. Chem. Earth 28 (2003), 647–652.
10. Zhao, X., Kim, J., Cezar, C.A., Huebsch, N., Lee, K., Bouhadir, K., et al. Active scaffolds for on-demand drug and cell delivery. Proc. Natl. Acad. Sci. 108 (2011), 67–72.
11. Yarema, K., Molecular mechanisms for electromagnetic field biosensing. Zhang, X., Yarema, K., Xu, A., (eds.) Biological Effects of Static Magnetic Fields, 2017, Springer Nature Singapore Pte Ltd., Singapore Chapter 3.
12. Kim, J.-J., Singh, R.K., Seo, S.-J., Kim, T.-H., Kim, J.-H., Lee, E.-J., et al. Magnetic scaffolds of polycaprolactone with functionalized magnetite nanoparticles: physicochemical, mechanical, and biological properties effective for bone regeneration. RSC Adv. 4 (2014), 17325–17336.
13. Tampieri, A., Iafisco, M., Sandri, M., Panseri, S., Cunha, C., Sprio, S., et al. Magnetic bioinspired hybrid nanostructured collagen–hydroxyapatite scaffolds supporting cell proliferation and tuning regenerative process. ACS Appl. Mater. Interfaces 6 (2014), 07–15697.
14. Meng, J., Xiao, B., Zhang, Y., Liu, J., Xue, H., Lei, J., et al. Super-paramagnetic responsive nanofibrous scaffolds under static magnetic field enhance osteogenesis for bone repair in vivo. Sci. Rep., 3, 2013, 2655.
15. Xu, H.-Y., Gu, N., Magnetic responsive scaffolds and magnetic fields in bone repair and regeneration. Front. Mater. Sci. 8 (2014), 20–31.
16. Bock, N., Riminucci, A., Dionigi, C., Russo, A., Tampieri, A., Landi, E., et al. A novel route in bone tissue engineering: magnetic biomimetic scaffolds. Acta Biomater. 6 (2010), 786–796.
17. Bueno, V.B., Takahashi, S.H., Catalani, L.H., de Torresi, S.I.C., Petri, D.F.S., Biocompatible xanthan/polypyrrole scaffolds for tissue engineering. Mater. Sci. Eng. C 52 (2015), 121–128.
18. Lee, K.Y., Mooney, D.J., Alginate: properties and biomedical applications. Prog. Polym. Sci. 37 (2012), 106–126.
19. Petri, D.F., Xanthan gum: a versatile biopolymer for biomedical and technological applications. J. Appl. Polym. Sci., 132, 2015, 42035.
20. Mohammed, Z., Haque, A., Richardson, R., Morris, E., P romotion and inhibition of xanthan ‘weak-gel'rheology by calcium ions. Carbohydr. Polym. 70 (2007), 38–45.
21. Dario, A.F., Hortencio, L.M., Sierakowski, M.R., Neto, J.C.Q., Petri, D.F., The effect of calcium salts on the viscosity and adsorption behavior of xanthan. Carbohydr. Polym. 84 (2011), 669–676.
22. Zeng, W., Oral controlled release formulation for highly water‐soluble drugs: drug–sodium alginate–xanthan gum–zinc acetate matrix. Drug Dev. Ind. Pharm. 30 (2004), 491–495.
23. Pongjanyakul, T., Puttipipatkhachorn, S., Xanthan–alginate composite gel beads: molecular interaction and in vitro characterization. Int. J. Pharm. 331 (2007), 61–71.
24. Lees, A.J., Hardy, J., Revesz, T., Parkinson's disease. J. Lancet 379 (2009), 2055–2066.
25. Kao, H.D., Traboulsi, A., Itoh, S., Dittert, L., Hussain, A., Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs. Pharm. Res. 17 (2000), 978–984.
26. Okereke, C.S., Kirby, L., Kumar, D., Cullen, E.I., Pratt, R.D., Hahne, W.A., Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Br. J. Clin. Pharmacol. 58 (2004), 41–49.
27. Pahwa, R., Lyons, K.E., Handbook of Parkinson's Disease. 2013, Crc Press.
28. Brooks, D.J., Optimizing levodopa therapy for Parkinson's disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective. Neuropsychiatr. Dis. Treat. 4 (2008), 39–44.
29. Bellini, M.Z., d. Oliva-Neto, P., Moraes, A.M., Properties of films obtained from biopolymers of different origins for skin lesions therapy. Braz. Arch. Biol. Technol. 58 (2015), 289–299.
30. Zhao, W., Odelius, K., Edlund, U., Zhao, C., Albertsson, A.-C., In situ synthesis of magnetic field-responsive hemicellulose hydrogels for drug delivery. Biomacromolecules 16 (2015), 2522–2528.
31. Hu, S.-H., Liu, T.-Y., Tsai, C.-H., Chen, S.-Y., Preparation and characterization of magnetic ferroscaffolds for tissue engineering. J. Magn. Magn. Mater. 310 (2007), 2871–2873.
32. Veiga, I.G., Moraes, A.M., Study of the swelling and stability properties of chitosan–xanthan membranes. J. Appl. Polym. Sci. 124 (2012), E154–E160.
33. Rodrigues, A.P., Saraiva Sanchez, E.M., da Costa, A.C., Moraes, A.M., The influence of preparation conditions on the characteristics of chitosan-alginate dressings for skin lesions. J. Appl. Polym. Sci. 109 (2008), 2703–2710.
34. Tan, J.M., Foo, J.B., Fakurazi, S., Hussein, M.Z., Release behaviour and toxicity evaluation of levodopa from carboxylated single-walled carbon nanotubes. Beilstein J. Nanotechnol. 6 (2015), 243–253.
35. http://www.druginfosys.com/drug.aspx?drugcode=415&type=1, Accessed on 30th January 2018.
36. Siepmann, J., Peppas, N., Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 64 (2012), 163–174.
37. Novaes, S.D., Oliveira, P.V., Petri, D.F.S., Hydroxypropyl methylcellulose sponges for the adsorption of estrogenic pollutant. ChemPlusChem 82 (2017), 904–913.
38. Harder, S., Baas, H., Bergemann, N., Demisch, L., Rietbrock, S., Concentration‐effect relationship of levodopa in patients with Parkinson's disease after oral administration of an immediate release and a controlled release formulation. Br. J. Clin. Pharmacol. 39 (1995), 39–44.
39. Rinne, U., Sonninen, V., Siirtola, T., Plasma concentration of levodopa in patients with Parkinson's disease. Eur. Neurol. 10 (1973), 301–310.
40. Lai, C.-T., Peter, H.Y., Dopamine-and l-β-3, 4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells: effects of oxidative stress and antioxidative factors. Biochem. Pharmacol. 53 (1997), 363–372.
41. Richard, I.H., Justus, A.W., Kurlan, R., Relationship between mood and motor fluctuations in Parkinson's disease. J. Neuropsychiatry Clin. Neurosci. 13 (2001), 35–41.
42. Stocchi, F., Optimising levodopa therapy for the management of Parkinson's disease. J. Neurol. 252 (2005), iv43–iv48.
43. Lopes, F.M., Schröder, R., da Frota Júnior, M.L.C., Zanotto-Filho, A., Müller, C.B., Pires, A.S., et al. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Res. 1337 (2010), 85–94.
44. Wang, Z., Sarje, A., Che, P.L., Yarema, K.J., Moderate strength (0. 23–0.28 T) static magnetic fields (SMF) modulate signaling and differentiation in human embryonic cells. BMC Genomics, 10, 2009, 356.
45. Wang, Z., Che, P.-L., Du, J., Ha, B., Yarema, K.J., Static magnetic field exposure reproduces cellular effects of the Parkinson's disease drug candidate ZM241385. PLoS One, 5, 2010, e13883.
46. Dini, L., Dwikat, M., Panzarini, E., Vergallo, C., Tenuzzo, B., Morphofunctional study of 12-O-tetradecanoyl-13-phorbol acetate (TPA)-induced differentiation of U937 cells under exposure to a 6 mT static magnetic field. Bioelectromagnetics 30 (2009), 352–364.
47. 2+influx. FASEB J. 13 (1999), 95–102.